EuroEyes continues its international expansion with the integration of FYEO into its global network, marking a significant step forward in the evolution of modern refractive eye care across Europe.
This development brings together FYEO’s strong local presence in the Netherlands with EuroEyes’ internationally recognised expertise in advanced vision correction. With more than 30 years of experience in laser eye surgery and lens implantation, EuroEyes has established itself as a leader in delivering high-quality, technology-led treatments designed to provide clear, natural vision without the need for glasses or contact lenses.
A Strategic Step Forward in European Eye Care
The transition follows a successful period of growth for FYEO under the majority ownership of Committed Capital, which has supported the clinic group since 2018. During this time, FYEO has implemented a strong expansion strategy, combining organic growth with targeted acquisitions to evolve from a local specialist provider into a national leader in refractive surgery.
This next phase ensures continuity for patients and healthcare professionals across the Netherlands, while introducing the additional strength of EuroEyes’ international infrastructure, clinical expertise and ongoing investment in innovation.
FYEO will continue to operate with its existing teams, surgeons and locations, maintaining its established standards of care while benefiting from closer collaboration within the EuroEyes group.
Building a Connected Network of Surgical Excellence
Founded in 1993 by Dr. Jørn Slot Jørgensen, EuroEyes has grown into one of the world’s leading providers of refractive surgery, with a network of clinics across Europe and Asia.
The group specialises in advanced procedures including SMILE® Pro, LASIK, lens replacement and Implantable Contact Lens (ICL) surgery, supported by continuous investment in cutting-edge technology and surgical development.
For patients in London and across the UK, this expansion reinforces EuroEyes’ position as a globally connected provider of vision correction, where local care is supported by international knowledge, shared clinical standards and access to some of the most advanced treatment pathways available today.
Leadership Reflections
Dr. Jørn Slot Jørgensen, Founder and CEO of EuroEyes, commented:
“We are delighted to welcome FYEO into the EuroEyes Group. FYEO has built a strong reputation in the Netherlands and shares the same values that define our approach: quality, expertise and personalised care for every patient. We look forward to working together and continuing to advance the field of refractive surgery.”
Rens Schoenmakers, CEO of FYEO, added:
“This marks an important milestone for FYEO. We remain committed to delivering the highest standards of care with a personal approach, while the partnership with EuroEyes allows us to grow, innovate and collaborate within a wider international network of specialists. It is a strong recognition of what our team has built.”
Albert van der Wal, Partner at Committed Capital, said:
“Since our investment in 2018, FYEO has achieved impressive growth and established a strong market position. EuroEyes provides the ideal platform for the next phase, combining international reach with deep expertise in refractive surgery.”
ما الذي يعنيه ذلك بالنسبة للمرضى
At its core, this expansion is about enhancing patient care.
Patients in the Netherlands will continue to receive treatment from the same trusted teams, now supported by the broader expertise and innovation of the EuroEyes network. This includes access to evolving surgical techniques, shared clinical insights and advanced technologies that continue to shape the future of vision correction.
For patients visiting EuroEyes clinics in London, this integration strengthens an already established commitment to precision, safety and personalised outcomes, ensuring that every treatment plan is guided by both local expertise and global experience.
A Shared Vision for the Future
The integration of FYEO into EuroEyes reflects a broader shift in refractive surgery, one that prioritises collaboration, innovation and long-term patient outcomes.
As the demand for advanced vision correction continues to grow, EuroEyes remains focused on delivering treatments that not only improve eyesight but enhance the way patients experience everyday life, from the clarity of a morning commute to the confidence of living without visual limitations.
